Protein S-100b as serum marker for prediction of functional outcome in metastatic spinal cord compression.
about
Malignant cord compression: A critical appraisal of prognostic factors predicting functional outcome after surgical treatmentEarly postoperative serum S100 beta levels predict ongoing brain damage after meningioma surgery: a prospective observational studyBiomarkers in spinal cord injury.The role of markers of inflammation in traumatic brain injury.The Next Generation of Biomarker Research in Spinal Cord Injury.Ex vivo 1H MR spectroscopy and histology after experimental chronic spinal cord compression.
P2860
Protein S-100b as serum marker for prediction of functional outcome in metastatic spinal cord compression.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Protein S-100b as serum marker ...... tatic spinal cord compression.
@en
Protein S-100b as serum marker ...... tatic spinal cord compression.
@nl
type
label
Protein S-100b as serum marker ...... tatic spinal cord compression.
@en
Protein S-100b as serum marker ...... tatic spinal cord compression.
@nl
prefLabel
Protein S-100b as serum marker ...... tatic spinal cord compression.
@en
Protein S-100b as serum marker ...... tatic spinal cord compression.
@nl
P2093
P1433
P1476
Protein S-100b as serum marker ...... tatic spinal cord compression.
@en
P2093
P2888
P304
P356
10.1007/S00701-004-0242-3
P577
2004-03-22T00:00:00Z